Holen Sie sich die Stockscreener-App
1.1897
2.16%
0.0297
Schlusskurs vom Vortag:
$1.16
Offen:
$1.16
24-Stunden-Volumen:
849.63K
Relative Volume:
0.27
Marktkapitalisierung:
$899.49M
Einnahmen:
$642.03M
Nettoeinkommen (Verlust:
$-180.42M
KGV:
-4.8225
EPS:
-0.2467
Netto-Cashflow:
$-212.06M
1W Leistung:
+0.42%
1M Leistung:
-3.66%
6M Leistung:
-15.36%
1J Leistung:
-31.10%
1-Tages-Spanne:
$1.16
$1.20
1-Wochen-Bereich:
$1.14
$1.22
52-Wochen-Spanne:
$1.11
$1.87
Opko Health Inc Stock (OPK) Company Profile
Firmenname
Opko Health Inc
Sektor
Branche
Telefon
305-575-4181
Adresse
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.185 | 880.52M | 642.03M | -180.42M | -212.06M | -0.2467 |
|
TMO
Thermo Fisher Scientific Inc
|
469.68 | 176.79B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
186.48 | 131.71B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
570.31 | 45.48B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.60 | 31.55B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
284.42 | 27.79B | 3.17B | 642.63M | 516.49M | 10.77 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-20 | Eingeleitet | JP Morgan | Neutral |
| 2025-10-31 | Herabstufung | Jefferies | Buy → Hold |
| 2025-04-25 | Eingeleitet | JP Morgan | Neutral |
| 2023-06-29 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-01-24 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2019-11-25 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-03-02 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-09-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2016-06-21 | Bestätigt | Standpoint Research | Buy |
| 2016-06-03 | Eingeleitet | Standpoint Research | Buy |
| 2016-03-31 | Bestätigt | Barrington Research | Outperform |
| 2015-10-16 | Eingeleitet | JP Morgan | Overweight |
| 2015-09-11 | Herabstufung | Jefferies | Buy → Hold |
| 2015-03-03 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2014-05-12 | Bestätigt | Oppenheimer | Outperform |
| 2014-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2013-11-13 | Bestätigt | Ladenburg Thalmann | Buy |
| 2013-05-30 | Bestätigt | Ladenburg Thalmann | Buy |
| 2012-10-22 | Eingeleitet | Barrington Research | Outperform |
| 2011-12-01 | Bestätigt | Ladenburg Thalmann | Buy |
| 2011-07-14 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Opko Health Inc Aktie (OPK) Neueste Nachrichten
Support Test: What is the Moat Score of OPKO Health Inc2026 Chart Watch & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Quarterly Earnings: Will OPKO Health Inc benefit from seasonalityMarket Activity Report & Risk Controlled Daily Plans - baoquankhu1.vn
OPKO Health (NASDAQ:OPK) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
Growth Report: Is OPKO Health Inc likely to announce a buybackSwing Trade & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
HC Wainwright Has Weak Forecast for OPKO Health Q4 Earnings - MarketBeat
Opko Health, Inc. (OPK) Stock Analysis: Exploring a 174% Potential Upside Amidst Challenging Fundamentals - DirectorsTalk Interviews
OPK PE Ratio & Valuation, Is OPK Overvalued - Intellectia AI
OPKO Health to Participate in Jefferies Biotech Summit - National Today
OPKO Health (NASDAQ:OPK) Given New $1.50 Price Target at Barrington Research - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Q4 2025 Earnings Call Transcript - Insider Monkey
OPKO Health (OPK) Loss Worsens To US$0.30 TTM EPS Challenging Turnaround Narratives - Sahm
OPK Should I Buy - Intellectia AI
OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts - Yahoo Finance
OPKO Health, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit - marketscreener.com
OPKO Health Beats Q4 Earnings Estimates - National Today
OPKO Health Q4 Earnings Call Highlights - MarketBeat
OPKO Health Inc (OPK) Q4 2025 Earnings Call Highlights: Strategic Divestitures and Promising ... By GuruFocus - Investing.com Canada
OPKO Health (NASDAQ:OPK) Announces Earnings Results - MarketBeat
OPKO Health (OPK) Q4 2025 Earnings Call Transcript - The Globe and Mail
OPKO Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: OPKO Health beats Q4 2025 EPS forecast, stock dips - Investing.com
OPKO Health: Q4 Earnings Snapshot - marketscreener.com
OPKO Health Q4 revenue falls - TradingView
Earnings Breakdown: OPKO Health Q4 - Benzinga
OPKO Health, Inc. Reports Q4 2025 Financial Results and 2026 Guidance, Highlights Key Collaborations and Innovations - Quiver Quantitative
OPK: Q4 2025 saw lower revenues and a net loss, but strong R&D progress and new partnerships - TradingView
OPKO Health (NASDAQ: OPK) restructures labs, leans on NGENLA and 4Kscore growth - Stock Titan
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results - GlobeNewswire
OPKO Health: Fourth Quarter Financial Overview - Bitget
OPKO Health Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Opko Health, Inc. (OPK) Stock Analysis: A Closer Look At Its 209% Potential Upside - DirectorsTalk Interviews
Revenue Check: Is OPKO Health Inc likely to announce a buyback2025 Performance Recap & Growth Focused Entry Reports - baoquankhu1.vn
Brokerages Set OPKO Health, Inc. (NASDAQ:OPK) Target Price at $2.28 - Defense World
Total debt per share of OPKO Health, Inc. – LSE:0KCS - TradingView
OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026? - The Globe and Mail
OPKO Health (OPK) Projected to Post Quarterly Earnings on Thursday - MarketBeat
MSN Money - MSN
Can OPKO Health's pipeline progress and deals drive growth in 2026? - MSN
Opko Health Inc. (OPK) Builds Value Through Partnerships and Innovation - Finviz
Opko Health, Inc. (OPK) Investor Outlook: Unpacking The 189.30% Potential Upside - DirectorsTalk Interviews
11 Best High Return Penny Stocks to Buy Right Now - Insider Monkey
Esoteric Testing Market: Generated Opportunities and Future - openPR.com
Why OPKO Health Inc. stock is favored by top institutionsJuly 2025 Snapshot & Accurate Buy Signal Notifications - mfd.ru
OPKO Health, Inc. to Announce 2025 Financial Results on February 26, 2026 - Quiver Quantitative
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 - OPKO Health, Inc.
What is the long term forecast for OPKO Health Inc. stockWall Street Watch & AI Enhanced Trade Execution Alerts - mfd.ru
OPKO Health Insider Ups Holding During Year - Yahoo Finance
Finanzdaten der Opko Health Inc-Aktie (OPK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Opko Health Inc-Aktie (OPK) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 20 '25 |
Buy |
1.33 |
580,000 |
771,328 |
216,126,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 19 '25 |
Buy |
1.31 |
580,000 |
759,115 |
215,546,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 18 '25 |
Buy |
1.27 |
533,300 |
678,906 |
214,966,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Oct 31 '25 |
Buy |
1.42 |
150,000 |
213,435 |
214,386,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Aug 08 '25 |
Buy |
1.32 |
675,000 |
891,000 |
214,676,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 10 '25 |
Buy |
1.36 |
125,000 |
169,712 |
214,001,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 08 '25 |
Buy |
1.48 |
125,000 |
184,650 |
213,876,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 01 '25 |
Buy |
1.65 |
100,000 |
164,850 |
213,751,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 28 '25 |
Buy |
1.70 |
150,000 |
254,385 |
213,651,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 17 '25 |
Buy |
1.74 |
200,000 |
347,820 |
213,501,448 |
0.77%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):